These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36788585)

  • 1. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
    Terp SK; Stoico MP; Dybkær K; Pedersen IS
    Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review.
    Rapado-González Ó; Salta S; López-López R; Henrique R; Suárez-Cunqueiro MM; Jerónimo C
    Clin Epigenetics; 2024 Aug; 16(1):105. PubMed ID: 39138540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
    Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
    Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of multiplex nested methylated specific PCR in early diagnosis of epithelial ovarian cancer.
    Wang B; Yu L; Yang GZ; Luo X; Huang L
    Asian Pac J Cancer Prev; 2015; 16(7):3003-7. PubMed ID: 25854397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer detection by DNA methylation in cervical scrapings.
    Wu TI; Huang RL; Su PH; Mao SP; Wu CH; Lai HC
    Clin Epigenetics; 2019 Nov; 11(1):166. PubMed ID: 31775891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer.
    Xing BL; Li T; Tang ZH; Jiao L; Ge SM; Qiang X; OuYang J
    Genet Mol Res; 2015 May; 14(2):4532-40. PubMed ID: 25966226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.
    Widschwendter M; Zikan M; Wahl B; Lempiäinen H; Paprotka T; Evans I; Jones A; Ghazali S; Reisel D; Eichner J; Rujan T; Yang Z; Teschendorff AE; Ryan A; Cibula D; Menon U; Wittenberger T
    Genome Med; 2017 Dec; 9(1):116. PubMed ID: 29268796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
    S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HOXA9 methylated ctDNA in ovarian cancer using sense-antisense measurement.
    Faaborg L; Fredslund Andersen R; Waldstrøm M; Høgdall E; Høgdall C; Adimi P; Jakobsen A; Dahl Steffensen K
    Clin Chim Acta; 2021 Nov; 522():152-157. PubMed ID: 34419462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation.
    Gao Y; Zhou N; Liu J
    Cancer Control; 2024; 31():10732748241255548. PubMed ID: 38764160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
    Liang L; Zhang Y; Li C; Liao Y; Wang G; Xu J; Li Y; Yuan G; Sun Y; Zhang R; Li X; Nian W; Zhao J; Zhang Y; Zhu X; Wen X; Cai S; Li N; Wu L
    EBioMedicine; 2022 Sep; 83():104222. PubMed ID: 35973389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
    Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
    Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
    Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
    Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
    Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
    Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of ovarian cancer using plasma cell-free DNA methylomes.
    Lu H; Liu Y; Wang J; Fu S; Wang L; Huang C; Li J; Xie L; Wang D; Li D; Zhou H; Rao Q
    Clin Epigenetics; 2022 Jun; 14(1):74. PubMed ID: 35681212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.
    Wasenang W; Chaiyarit P; Proungvitaya S; Limpaiboon T
    Clin Epigenetics; 2019 Mar; 11(1):39. PubMed ID: 30832707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating methylated opioid binding protein/cell adhesion molecule-like gene as a biomarker for ovarian carcinoma.
    Zhou F; Ma M; Tao G; Chen X; Xie W; Wang Y; Cao X
    Clin Lab; 2014; 60(5):759-65. PubMed ID: 24839818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.